Literature DB >> 17638356

Chemical stability of midazolam injection by high performance liquid chromatography.

Marta de Diego1, Gloria Godoy, Sigrid Mennickent.   

Abstract

The chemical stability of midazolam hydrochloride injection, undiluted or diluted with dextrose sterile solution, was studied at different storage conditions by LC. The study was performed at room temperature (23 +/- 2 degrees C) under light exposure and light protection, +8 +/- 1 degrees C and -20 +/- 0.5 degrees C, in glass and plastic containers over 14 days with midazolam hydrochloride injection, undiluted or diluted with 5% dextrose sterile solution. Chromatographic separation was carried out on a RP-18(e) column, using a mobile phase consisting of ACN-phosphate buffer (pH 3.3; 0.1 M) (30:70 v/v) at a flow rate of 1.0 mL/min and UV detection at 220 nm. The concentrations of all samples remained greater than 90% of the original concentration. The chromatographic assay exhibited an adequate linearity (r(2) >0.999), selectivity, precision (RSD <3.1), and accuracy (recoveries from 100.46 to 101.40%). Injectable midazolam hydrochloride was chemically stable in all conditions that were studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638356     DOI: 10.1002/jssc.200700006

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  2 in total

1.  Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer.

Authors:  Seydou Sanogo; Paolo Silimbani; Raffaella Gaggeri; Romina Rossi; Lisa Elviri; Marco Maltoni; Carla Masini
Journal:  Eur J Hosp Pharm       Date:  2018-05-15

2.  Therapeutic Treatment Plan Optimization during the COVID-19 Pandemic: A Comprehensive Physicochemical Compatibility Study of Intensive Care Units Selected Drugs.

Authors:  Maria Gloria Tarantini; Stéphanie Ramos; Philippe-Henri Secrétan; Laura Guichard; Lamia Hassani; Agnès Bellanger; Julien Mayaux; Patrick Tilleul; Fadwa El Kouari; Hassane Sadou Yayé
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.